Close

Kite Pharma (KITE) CMO Chang Says R&D Pipeline 'Well Balanced' Between Blood, Solid Tumors - Investor Day

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. MSFT


Go back to Kite Pharma (KITE) CMO Chang Says R&D Pipeline 'Well Balanced' Between Blood, Solid Tumors - Investor Day
(NASDAQ: KITE) Delayed: 179.79 --0 (-0%)
Previous Close $179.79    52 Week High $89.84 
Open $17.44    52 Week Low $38.41 
Day High $179.79    P/E N/A 
Day Low $179.79    EPS $0.00 
Volume 146,685